
Bristol Myers Squibb Buys Nvidia Vera Rubin AI System for Drug Discovery
Bristol Myers Squibb is buying an Nvidia DGX SuperPOD built on Vera Rubin to expand AI across drug discovery and development. The move points to a broader shift from AI pilots to shared, production-grade research infrastructure in pharma.

Rohit Kumar
Latest editorial briefing





